A Phase 1 Study of AZD9833 in Japanese Women with ER Positive, HER2 Negative Advanced Breast Cancer

Trial Identifier:	D8530C00006
Sponsor:	AstraZeneca
Start Date:	September 2020
Primary Completion Date:	July 2022
Study Completion Date:	June 2025
Condition:	Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Chuo-ku, JP, 104-0045
JP	Kashiwa, JP, 277-8577
JP	Koto-ku, JP, 135-8550

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.